COVID-19 Impact on Global Pre-Menstrual Syndrome Market Size, Status and Forecast 2020-2026

September 2020 | 92 pages | ID: C34618D03560EN
QYResearch

Abstracts

This report focuses on the global Pre-Menstrual Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pre-Menstrual Syndrome development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Alva-Amco Pharmacal Cos., Inc.
• Bayer, Inc.
• Chattem, Inc. (Sanofi)
• DEKK-TEC, Inc.
• G. R. Lane Health Products Ltd
• McNeil Consumer Healthcare
• MetP Pharma AG
• Pherin Pharmaceuticals, Inc.
• Umecrine Mood AB
• Novartis AG
• GlaxoSmithKline Plc

Market segment by Type, the product can be split into

• Analgesics (Pain Killers)
• Oral Contraceptive Pills (OCPs)
• Gonadotropin-Releasing Hormone (GnRH)
• Antidepressants
• Ovarian Suppressors
• Diuretics
• Benzodiazepines

Market segment by Application, split into

• Hospitals
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Pre-Menstrual Syndrome status, future forecast, growth opportunity, key market and key players.
• To present the Pre-Menstrual Syndrome development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pre-Menstrual Syndrome are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pre-Menstrual Syndrome Revenue
1.4 Market Analysis by Type
  1.4.1 Global Pre-Menstrual Syndrome Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Analgesics (Pain Killers)
  1.4.3 Oral Contraceptive Pills (OCPs)
  1.4.4 Gonadotropin-Releasing Hormone (GnRH)
  1.4.5 Antidepressants
  1.4.6 Ovarian Suppressors
  1.4.7 Diuretics
  1.4.8 Benzodiazepines
1.5 Market by Application
  1.5.1 Global Pre-Menstrual Syndrome Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pre-Menstrual Syndrome Industry Impact
  1.6.1 How the Covid-19 is Affecting the Pre-Menstrual Syndrome Industry
    1.6.1.1 Pre-Menstrual Syndrome Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Pre-Menstrual Syndrome Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Pre-Menstrual Syndrome Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Pre-Menstrual Syndrome Market Perspective (2015-2026)
2.2 Pre-Menstrual Syndrome Growth Trends by Regions
  2.2.1 Pre-Menstrual Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pre-Menstrual Syndrome Historic Market Share by Regions (2015-2020)
  2.2.3 Pre-Menstrual Syndrome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pre-Menstrual Syndrome Market Growth Strategy
  2.3.6 Primary Interviews with Key Pre-Menstrual Syndrome Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pre-Menstrual Syndrome Players by Market Size
  3.1.1 Global Top Pre-Menstrual Syndrome Players by Revenue (2015-2020)
  3.1.2 Global Pre-Menstrual Syndrome Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pre-Menstrual Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pre-Menstrual Syndrome Market Concentration Ratio
  3.2.1 Global Pre-Menstrual Syndrome Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pre-Menstrual Syndrome Revenue in 2019
3.3 Pre-Menstrual Syndrome Key Players Head office and Area Served
3.4 Key Players Pre-Menstrual Syndrome Product Solution and Service
3.5 Date of Enter into Pre-Menstrual Syndrome Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Pre-Menstrual Syndrome Historic Market Size by Type (2015-2020)
4.2 Global Pre-Menstrual Syndrome Forecasted Market Size by Type (2021-2026)

5 PRE-MENSTRUAL SYNDROME BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Pre-Menstrual Syndrome Market Size by Application (2015-2020)
5.2 Global Pre-Menstrual Syndrome Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pre-Menstrual Syndrome Market Size (2015-2020)
6.2 Pre-Menstrual Syndrome Key Players in North America (2019-2020)
6.3 North America Pre-Menstrual Syndrome Market Size by Type (2015-2020)
6.4 North America Pre-Menstrual Syndrome Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pre-Menstrual Syndrome Market Size (2015-2020)
7.2 Pre-Menstrual Syndrome Key Players in Europe (2019-2020)
7.3 Europe Pre-Menstrual Syndrome Market Size by Type (2015-2020)
7.4 Europe Pre-Menstrual Syndrome Market Size by Application (2015-2020)

8 CHINA

8.1 China Pre-Menstrual Syndrome Market Size (2015-2020)
8.2 Pre-Menstrual Syndrome Key Players in China (2019-2020)
8.3 China Pre-Menstrual Syndrome Market Size by Type (2015-2020)
8.4 China Pre-Menstrual Syndrome Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pre-Menstrual Syndrome Market Size (2015-2020)
9.2 Pre-Menstrual Syndrome Key Players in Japan (2019-2020)
9.3 Japan Pre-Menstrual Syndrome Market Size by Type (2015-2020)
9.4 Japan Pre-Menstrual Syndrome Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pre-Menstrual Syndrome Market Size (2015-2020)
10.2 Pre-Menstrual Syndrome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pre-Menstrual Syndrome Market Size by Type (2015-2020)
10.4 Southeast Asia Pre-Menstrual Syndrome Market Size by Application (2015-2020)

11 INDIA

11.1 India Pre-Menstrual Syndrome Market Size (2015-2020)
11.2 Pre-Menstrual Syndrome Key Players in India (2019-2020)
11.3 India Pre-Menstrual Syndrome Market Size by Type (2015-2020)
11.4 India Pre-Menstrual Syndrome Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pre-Menstrual Syndrome Market Size (2015-2020)
12.2 Pre-Menstrual Syndrome Key Players in Central & South America (2019-2020)
12.3 Central & South America Pre-Menstrual Syndrome Market Size by Type (2015-2020)
12.4 Central & South America Pre-Menstrual Syndrome Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Alva-Amco Pharmacal Cos., Inc.
  13.1.1 Alva-Amco Pharmacal Cos., Inc. Company Details
  13.1.2 Alva-Amco Pharmacal Cos., Inc. Business Overview and Its Total Revenue
  13.1.3 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Introduction
  13.1.4 Alva-Amco Pharmacal Cos., Inc. Revenue in Pre-Menstrual Syndrome Business (2015-2020))
  13.1.5 Alva-Amco Pharmacal Cos., Inc. Recent Development
13.2 Bayer, Inc.
  13.2.1 Bayer, Inc. Company Details
  13.2.2 Bayer, Inc. Business Overview and Its Total Revenue
  13.2.3 Bayer, Inc. Pre-Menstrual Syndrome Introduction
  13.2.4 Bayer, Inc. Revenue in Pre-Menstrual Syndrome Business (2015-2020)
  13.2.5 Bayer, Inc. Recent Development
13.3 Chattem, Inc. (Sanofi)
  13.3.1 Chattem, Inc. (Sanofi) Company Details
  13.3.2 Chattem, Inc. (Sanofi) Business Overview and Its Total Revenue
  13.3.3 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Introduction
  13.3.4 Chattem, Inc. (Sanofi) Revenue in Pre-Menstrual Syndrome Business (2015-2020)
  13.3.5 Chattem, Inc. (Sanofi) Recent Development
13.4 DEKK-TEC, Inc.
  13.4.1 DEKK-TEC, Inc. Company Details
  13.4.2 DEKK-TEC, Inc. Business Overview and Its Total Revenue
  13.4.3 DEKK-TEC, Inc. Pre-Menstrual Syndrome Introduction
  13.4.4 DEKK-TEC, Inc. Revenue in Pre-Menstrual Syndrome Business (2015-2020)
  13.4.5 DEKK-TEC, Inc. Recent Development
13.5 G. R. Lane Health Products Ltd
  13.5.1 G. R. Lane Health Products Ltd Company Details
  13.5.2 G. R. Lane Health Products Ltd Business Overview and Its Total Revenue
  13.5.3 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Introduction
  13.5.4 G. R. Lane Health Products Ltd Revenue in Pre-Menstrual Syndrome Business (2015-2020)
  13.5.5 G. R. Lane Health Products Ltd Recent Development
13.6 McNeil Consumer Healthcare
  13.6.1 McNeil Consumer Healthcare Company Details
  13.6.2 McNeil Consumer Healthcare Business Overview and Its Total Revenue
  13.6.3 McNeil Consumer Healthcare Pre-Menstrual Syndrome Introduction
  13.6.4 McNeil Consumer Healthcare Revenue in Pre-Menstrual Syndrome Business (2015-2020)
  13.6.5 McNeil Consumer Healthcare Recent Development
13.7 MetP Pharma AG
  13.7.1 MetP Pharma AG Company Details
  13.7.2 MetP Pharma AG Business Overview and Its Total Revenue
  13.7.3 MetP Pharma AG Pre-Menstrual Syndrome Introduction
  13.7.4 MetP Pharma AG Revenue in Pre-Menstrual Syndrome Business (2015-2020)
  13.7.5 MetP Pharma AG Recent Development
13.8 Pherin Pharmaceuticals, Inc.
  13.8.1 Pherin Pharmaceuticals, Inc. Company Details
  13.8.2 Pherin Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.8.3 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Introduction
  13.8.4 Pherin Pharmaceuticals, Inc. Revenue in Pre-Menstrual Syndrome Business (2015-2020)
  13.8.5 Pherin Pharmaceuticals, Inc. Recent Development
13.9 Umecrine Mood AB
  13.9.1 Umecrine Mood AB Company Details
  13.9.2 Umecrine Mood AB Business Overview and Its Total Revenue
  13.9.3 Umecrine Mood AB Pre-Menstrual Syndrome Introduction
  13.9.4 Umecrine Mood AB Revenue in Pre-Menstrual Syndrome Business (2015-2020)
  13.9.5 Umecrine Mood AB Recent Development
13.10 Novartis AG
  13.10.1 Novartis AG Company Details
  13.10.2 Novartis AG Business Overview and Its Total Revenue
  13.10.3 Novartis AG Pre-Menstrual Syndrome Introduction
  13.10.4 Novartis AG Revenue in Pre-Menstrual Syndrome Business (2015-2020)
  13.10.5 Novartis AG Recent Development
13.11 GlaxoSmithKline Plc
  10.11.1 GlaxoSmithKline Plc Company Details
  10.11.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
  10.11.3 GlaxoSmithKline Plc Pre-Menstrual Syndrome Introduction
  10.11.4 GlaxoSmithKline Plc Revenue in Pre-Menstrual Syndrome Business (2015-2020)
  10.11.5 GlaxoSmithKline Plc Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pre-Menstrual Syndrome Key Market Segments
Table 2. Key Players Covered: Ranking by Pre-Menstrual Syndrome Revenue
Table 3. Ranking of Global Top Pre-Menstrual Syndrome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pre-Menstrual Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Analgesics (Pain Killers)
Table 6. Key Players of Oral Contraceptive Pills (OCPs)
Table 7. Key Players of Gonadotropin-Releasing Hormone (GnRH)
Table 8. Key Players of Antidepressants
Table 9. Key Players of Ovarian Suppressors
Table 10. Key Players of Diuretics
Table 11. Key Players of Benzodiazepines
Table 12. COVID-19 Impact Global Market: (Four Pre-Menstrual Syndrome Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Pre-Menstrual Syndrome Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Pre-Menstrual Syndrome Players to Combat Covid-19 Impact
Table 17. Global Pre-Menstrual Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Pre-Menstrual Syndrome Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Pre-Menstrual Syndrome Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Pre-Menstrual Syndrome Market Share by Regions (2015-2020)
Table 21. Global Pre-Menstrual Syndrome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Pre-Menstrual Syndrome Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Pre-Menstrual Syndrome Market Growth Strategy
Table 27. Main Points Interviewed from Key Pre-Menstrual Syndrome Players
Table 28. Global Pre-Menstrual Syndrome Revenue by Players (2015-2020) (Million US$)
Table 29. Global Pre-Menstrual Syndrome Market Share by Players (2015-2020)
Table 30. Global Top Pre-Menstrual Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Menstrual Syndrome as of 2019)
Table 31. Global Pre-Menstrual Syndrome by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Pre-Menstrual Syndrome Product Solution and Service
Table 34. Date of Enter into Pre-Menstrual Syndrome Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Pre-Menstrual Syndrome Market Size by Type (2015-2020) (Million US$)
Table 37. Global Pre-Menstrual Syndrome Market Size Share by Type (2015-2020)
Table 38. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2021-2026)
Table 39. Global Pre-Menstrual Syndrome Market Size Share by Application (2015-2020)
Table 40. Global Pre-Menstrual Syndrome Market Size by Application (2015-2020) (Million US$)
Table 41. Global Pre-Menstrual Syndrome Market Size Share by Application (2021-2026)
Table 42. North America Key Players Pre-Menstrual Syndrome Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Pre-Menstrual Syndrome Market Share (2019-2020)
Table 44. North America Pre-Menstrual Syndrome Market Size by Type (2015-2020) (Million US$)
Table 45. North America Pre-Menstrual Syndrome Market Share by Type (2015-2020)
Table 46. North America Pre-Menstrual Syndrome Market Size by Application (2015-2020) (Million US$)
Table 47. North America Pre-Menstrual Syndrome Market Share by Application (2015-2020)
Table 48. Europe Key Players Pre-Menstrual Syndrome Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Pre-Menstrual Syndrome Market Share (2019-2020)
Table 50. Europe Pre-Menstrual Syndrome Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Pre-Menstrual Syndrome Market Share by Type (2015-2020)
Table 52. Europe Pre-Menstrual Syndrome Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Pre-Menstrual Syndrome Market Share by Application (2015-2020)
Table 54. China Key Players Pre-Menstrual Syndrome Revenue (2019-2020) (Million US$)
Table 55. China Key Players Pre-Menstrual Syndrome Market Share (2019-2020)
Table 56. China Pre-Menstrual Syndrome Market Size by Type (2015-2020) (Million US$)
Table 57. China Pre-Menstrual Syndrome Market Share by Type (2015-2020)
Table 58. China Pre-Menstrual Syndrome Market Size by Application (2015-2020) (Million US$)
Table 59. China Pre-Menstrual Syndrome Market Share by Application (2015-2020)
Table 60. Japan Key Players Pre-Menstrual Syndrome Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Pre-Menstrual Syndrome Market Share (2019-2020)
Table 62. Japan Pre-Menstrual Syndrome Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Pre-Menstrual Syndrome Market Share by Type (2015-2020)
Table 64. Japan Pre-Menstrual Syndrome Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Pre-Menstrual Syndrome Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Pre-Menstrual Syndrome Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Pre-Menstrual Syndrome Market Share (2019-2020)
Table 68. Southeast Asia Pre-Menstrual Syndrome Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Pre-Menstrual Syndrome Market Share by Type (2015-2020)
Table 70. Southeast Asia Pre-Menstrual Syndrome Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Pre-Menstrual Syndrome Market Share by Application (2015-2020)
Table 72. India Key Players Pre-Menstrual Syndrome Revenue (2019-2020) (Million US$)
Table 73. India Key Players Pre-Menstrual Syndrome Market Share (2019-2020)
Table 74. India Pre-Menstrual Syndrome Market Size by Type (2015-2020) (Million US$)
Table 75. India Pre-Menstrual Syndrome Market Share by Type (2015-2020)
Table 76. India Pre-Menstrual Syndrome Market Size by Application (2015-2020) (Million US$)
Table 77. India Pre-Menstrual Syndrome Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Pre-Menstrual Syndrome Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Pre-Menstrual Syndrome Market Share (2019-2020)
Table 80. Central & South America Pre-Menstrual Syndrome Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Pre-Menstrual Syndrome Market Share by Type (2015-2020)
Table 82. Central & South America Pre-Menstrual Syndrome Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Pre-Menstrual Syndrome Market Share by Application (2015-2020)
Table 84. Alva-Amco Pharmacal Cos., Inc. Company Details
Table 85. Alva-Amco Pharmacal Cos., Inc. Business Overview
Table 86. Alva-Amco Pharmacal Cos., Inc. Product
Table 87. Alva-Amco Pharmacal Cos., Inc. Revenue in Pre-Menstrual Syndrome Business (2015-2020) (Million US$)
Table 88. Alva-Amco Pharmacal Cos., Inc. Recent Development
Table 89. Bayer, Inc. Company Details
Table 90. Bayer, Inc. Business Overview
Table 91. Bayer, Inc. Product
Table 92. Bayer, Inc. Revenue in Pre-Menstrual Syndrome Business (2015-2020) (Million US$)
Table 93. Bayer, Inc. Recent Development
Table 94. Chattem, Inc. (Sanofi) Company Details
Table 95. Chattem, Inc. (Sanofi) Business Overview
Table 96. Chattem, Inc. (Sanofi) Product
Table 97. Chattem, Inc. (Sanofi) Revenue in Pre-Menstrual Syndrome Business (2015-2020) (Million US$)
Table 98. Chattem, Inc. (Sanofi) Recent Development
Table 99. DEKK-TEC, Inc. Company Details
Table 100. DEKK-TEC, Inc. Business Overview
Table 101. DEKK-TEC, Inc. Product
Table 102. DEKK-TEC, Inc. Revenue in Pre-Menstrual Syndrome Business (2015-2020) (Million US$)
Table 103. DEKK-TEC, Inc. Recent Development
Table 104. G. R. Lane Health Products Ltd Company Details
Table 105. G. R. Lane Health Products Ltd Business Overview
Table 106. G. R. Lane Health Products Ltd Product
Table 107. G. R. Lane Health Products Ltd Revenue in Pre-Menstrual Syndrome Business (2015-2020) (Million US$)
Table 108. G. R. Lane Health Products Ltd Recent Development
Table 109. McNeil Consumer Healthcare Company Details
Table 110. McNeil Consumer Healthcare Business Overview
Table 111. McNeil Consumer Healthcare Product
Table 112. McNeil Consumer Healthcare Revenue in Pre-Menstrual Syndrome Business (2015-2020) (Million US$)
Table 113. McNeil Consumer Healthcare Recent Development
Table 114. MetP Pharma AG Company Details
Table 115. MetP Pharma AG Business Overview
Table 116. MetP Pharma AG Product
Table 117. MetP Pharma AG Revenue in Pre-Menstrual Syndrome Business (2015-2020) (Million US$)
Table 118. MetP Pharma AG Recent Development
Table 119. Pherin Pharmaceuticals, Inc. Business Overview
Table 120. Pherin Pharmaceuticals, Inc. Product
Table 121. Pherin Pharmaceuticals, Inc. Company Details
Table 122. Pherin Pharmaceuticals, Inc. Revenue in Pre-Menstrual Syndrome Business (2015-2020) (Million US$)
Table 123. Pherin Pharmaceuticals, Inc. Recent Development
Table 124. Umecrine Mood AB Company Details
Table 125. Umecrine Mood AB Business Overview
Table 126. Umecrine Mood AB Product
Table 127. Umecrine Mood AB Revenue in Pre-Menstrual Syndrome Business (2015-2020) (Million US$)
Table 128. Umecrine Mood AB Recent Development
Table 129. Novartis AG Company Details
Table 130. Novartis AG Business Overview
Table 131. Novartis AG Product
Table 132. Novartis AG Revenue in Pre-Menstrual Syndrome Business (2015-2020) (Million US$)
Table 133. Novartis AG Recent Development
Table 134. GlaxoSmithKline Plc Company Details
Table 135. GlaxoSmithKline Plc Business Overview
Table 136. GlaxoSmithKline Plc Product
Table 137. GlaxoSmithKline Plc Revenue in Pre-Menstrual Syndrome Business (2015-2020) (Million US$)
Table 138. GlaxoSmithKline Plc Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pre-Menstrual Syndrome Market Share by Type: 2020 VS 2026
Figure 2. Analgesics (Pain Killers) Features
Figure 3. Oral Contraceptive Pills (OCPs) Features
Figure 4. Gonadotropin-Releasing Hormone (GnRH) Features
Figure 5. Antidepressants Features
Figure 6. Ovarian Suppressors Features
Figure 7. Diuretics Features
Figure 8. Benzodiazepines Features
Figure 9. Global Pre-Menstrual Syndrome Market Share by Application: 2020 VS 2026
Figure 10. Hospitals Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Pre-Menstrual Syndrome Report Years Considered
Figure 14. Global Pre-Menstrual Syndrome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Pre-Menstrual Syndrome Market Share by Regions: 2020 VS 2026
Figure 16. Global Pre-Menstrual Syndrome Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Pre-Menstrual Syndrome Market Share by Players in 2019
Figure 19. Global Top Pre-Menstrual Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Menstrual Syndrome as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Pre-Menstrual Syndrome Revenue in 2019
Figure 21. North America Pre-Menstrual Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Pre-Menstrual Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Pre-Menstrual Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Pre-Menstrual Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Pre-Menstrual Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Pre-Menstrual Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Pre-Menstrual Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Alva-Amco Pharmacal Cos., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Alva-Amco Pharmacal Cos., Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2015-2020)
Figure 30. Bayer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bayer, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2015-2020)
Figure 32. Chattem, Inc. (Sanofi) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Chattem, Inc. (Sanofi) Revenue Growth Rate in Pre-Menstrual Syndrome Business (2015-2020)
Figure 34. DEKK-TEC, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. DEKK-TEC, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2015-2020)
Figure 36. G. R. Lane Health Products Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. G. R. Lane Health Products Ltd Revenue Growth Rate in Pre-Menstrual Syndrome Business (2015-2020)
Figure 38. McNeil Consumer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. McNeil Consumer Healthcare Revenue Growth Rate in Pre-Menstrual Syndrome Business (2015-2020)
Figure 40. MetP Pharma AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. MetP Pharma AG Revenue Growth Rate in Pre-Menstrual Syndrome Business (2015-2020)
Figure 42. Pherin Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pherin Pharmaceuticals, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2015-2020)
Figure 44. Umecrine Mood AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Umecrine Mood AB Revenue Growth Rate in Pre-Menstrual Syndrome Business (2015-2020)
Figure 46. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Novartis AG Revenue Growth Rate in Pre-Menstrual Syndrome Business (2015-2020)
Figure 48. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GlaxoSmithKline Plc Revenue Growth Rate in Pre-Menstrual Syndrome Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed